Status:
UNKNOWN
The United Kingdom Multiple Sclerosis Register Covid-19 Substudy
Lead Sponsor:
Swansea University
Conditions:
Multiple Sclerosis
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to understand the impact of COVID-19 on People with Multiple Sclerosis in the United Kingdom.
Detailed Description
Study objectives 1. To identify the incidence of upper respiratory tract symptoms: fever, cough and breathing difficulties, other symptoms suggestive of COVID-19 infection, respiratory tract infectio...
Eligibility Criteria
Inclusion
- \>18 and confirmed diagnosis of MS, enrolled on UK MS Register
Exclusion
- None of the above
Key Trial Info
Start Date :
March 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 14 2022
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04354519
Start Date
March 14 2020
End Date
July 14 2022
Last Update
August 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swansea Univeristy
Swansea, United Kingdom, SA28PP